Provided by Tiger Trade Technology Pte. Ltd.

Relay Therapeutics

19.44
-0.2600-1.32%
Post-market: 19.500.0600+0.31%19:56 EDT
Volume:2.97M
Turnover:58.13M
Market Cap:4.26B
PE:-12.42
High:20.17
Open:19.92
Low:19.18
Close:19.70
52wk High:21.27
52wk Low:3.43
Shares:219.14M
Float Shares:145.00M
Volume Ratio:1.41
T/O Rate:2.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5651
EPS(LYR):-1.6113
ROE:-36.77%
ROA:-22.88%
PB:4.79
PE(LYR):-12.06

Loading ...

Relay Therapeutics Shares Fall 3.7% Premarket on $175 Mln Stock Offering

THOMSON REUTERS
·
May 20

Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Radnet (RDNT) and Relay Therapeutics (RLAY)

TIPRANKS
·
May 20

Relay Therapeutics Inc : Leerink Partners Raises Target Price to $29 From $23

THOMSON REUTERS
·
May 20

Relay Therapeutics Launches $175 Million Stock Offering; Shares Drop After Hours

MT Newswires Live
·
May 20

Relay Therapeutics launches $175 million common stock offering

Reuters
·
May 20

Relay Therapeutics Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
May 20

Relay Therapeutics upgraded at JonesResearch after zovegalisib data

TIPRANKS
·
May 20

Sector Update: Healthcare Stocks Rise Tuesday Afternoon

MT Newswires Live
·
May 20

Relay Therapeutics rises 8.6%

TIPRANKS
·
May 20

BUZZ-U.S. STOCKS ON THE MOVE-T1 Energy, Home Depot, X-Energy

Reuters
·
May 19

Relay Therapeutics price target raised to $26 from $23 at Raymond James

TIPRANKS
·
May 19

TD Cowen sees Relay’s Phase 2 zovegalisib data ‘a best-case scenario’

TIPRANKS
·
May 19

Why Is Relay Therapeutics Stock (RLAY) Up Today?

TIPRANKS
·
May 19

Relay Therapeutics reports promising Phase 2 zovegalisib data

TIPRANKS
·
May 19

Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Tuesday Amid Uncertainty Surrounding US-Iran Talks

MT Newswires Live
·
May 19

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, SiTime Corp, Hoth Therapeutics

Reuters
·
May 19

Relay Therapeutics up 11% in pre-market after zovegalisib update

TIPRANKS
·
May 19

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Relay Therapeutics, Amer Sports

Reuters
·
May 19

Relay Therapeutics Says 60% of Patients Responded in Rare Vascular Disorder Drug Study

MT Newswires Live
·
May 19

BUZZ-Relay Therapeutics rises after vascular disorder drug shows promise in study

Reuters
·
May 19